Literature DB >> 1618840

Purification and characterization of a novel proline-directed protein kinase from bovine brain.

J Lew1, K Beaudette, C M Litwin, J H Wang.   

Abstract

A novel protein kinase which phosphorylates a synthetic peptide substrate (RRPDAHRTPNRAF) has been purified approximately 200,000-fold from bovine brain. This peptide contains the consensus sequence for phosphorylation by the p34cdc2 kinase. The purification procedure took advantage of the phenomenon that this novel brain kinase, in partially purified extracts, chromatographed on a gel filtration column as a high molecular weight complex which dissociated in buffer containing 1 M NaCl. The purified native enzyme was estimated to be approximately 63,000, and displayed two bands of M(r) = 33,000 and 25,000 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. On Western immunoblot, the M(r) = 33,000 peptide reacted strongly with antibodies specific for a conserved amino-terminal sequence, weakly with antibodies to the conserved PSTAIRE sequence, and not at all with antibodies to the carboxyl terminus, of HeLa cell p34cdc2. The brain kinase and p34cdc2 were similar in displaying good activity toward the parent peptide substrate, but no activity toward peptide analogues in which the -T-P- motif was substituted with either -T-G- or -T-A-. Both kinases showed marked preference in phosphorylating a peptide derived from H1 histone (KTPKKAKKPKTPKKAKKL), and both kinases could be phosphorylated by the src-family tyrosine kinase, p56lyn, purified from bovine spleen. However, the brain kinase did not co-purify with a subunit having a molecular weight corresponding to known cyclins, nor did it undergo specific interaction with p13suc1 beads, suggesting that this enzyme is distinct from p34cdc2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618840

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Role of cyclins in neuronal differentiation of immortalized hippocampal cells.

Authors:  W Xiong; R Pestell; M R Rosner
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

2.  Neurabin-I is phosphorylated by Cdk5: implications for neuronal morphogenesis and cortical migration.

Authors:  Frédéric Causeret; Tom Jacobs; Mami Terao; Owen Heath; Mikio Hoshino; Margareta Nikolic
Journal:  Mol Biol Cell       Date:  2007-08-15       Impact factor: 4.138

3.  Phenotypical manifestations of partial trisomy 9 and monosomy 4 in two siblings.

Authors:  Matthew Vanlandingham; Tuan V Nguyen; Omar A Abdul-Rahman; Andrew Parent; Jun Zhang
Journal:  Neurol Sci       Date:  2008-11-27       Impact factor: 3.307

4.  The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death.

Authors:  En Huang; Dianbo Qu; Yi Zhang; Katerina Venderova; M Emdadul Haque; Maxime W C Rousseaux; Ruth S Slack; John M Woulfe; David S Park
Journal:  Nat Cell Biol       Date:  2010-05-16       Impact factor: 28.824

5.  The CDK5 activator, p39, binds specifically to myosin essential light chain.

Authors:  Dolena R Ledee; Brajendra K Tripathi; Peggy S Zelenka
Journal:  Biochem Biophys Res Commun       Date:  2007-01-29       Impact factor: 3.575

6.  Inhibition of neuronal cyclin-dependent kinase-5 by staurosporine and purine analogs is independent of activation by Munc-18.

Authors:  K T Shetty; N Amin; P Grant; R W Albers; H C Pant
Journal:  Neurochem Res       Date:  1996-05       Impact factor: 3.996

7.  Phosphorylation sensitizes microtubule-associated protein tau to Al(3+)-induced aggregation.

Authors:  W Li; K K Ma; W Sun; H K Paudel
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

8.  Cyclin-dependent kinase 5 phosphorylation of human septin SEPT5 (hCDCrel-1) modulates exocytosis.

Authors:  Niranjana D Amin; Ya-Li Zheng; Sashi Kesavapany; Jyotshnabala Kanungo; Tad Guszczynski; Ram K Sihag; Parvathi Rudrabhatla; Wayne Albers; Philip Grant; Harish C Pant
Journal:  J Neurosci       Date:  2008-04-02       Impact factor: 6.167

9.  p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.

Authors:  Lingyan Zhang; Wen Liu; Karen K Szumlinski; John Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-14       Impact factor: 11.205

10.  Characterization of a novel human CDK5 splicing variant that inhibits Wnt/beta-catenin signaling.

Authors:  Qiang Li; Xianghua Liu; Mingjun Zhang; Guangming Ye; Qian Qiao; Yichen Ling; Yanhua Wu; Yuanyuan Zhang; Long Yu
Journal:  Mol Biol Rep       Date:  2009-08-20       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.